[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University of Vigo\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":239},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,44,74,102,135,157,181,213],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100642415","effect-of-exercise-on-the-width-and-stiffness-of-the-linea-alba-in-postpartum-women-with-diastasis-100642415",false,"NCT07639125","Effect of Exercise on the Width and Stiffness of the Linea Alba in Postpartum Women With Diastasis","Inclusion Criteria:\n\n* Adult woman (\\> 18 years old)\n* Women who agreed to participate and provided written informed consent\n* Women between 6 and 12 weeks postpartum at the time of recruitment.\n\nExclusion Criteria:\n\n* History of previous abdominal surgery ( except cesarean section)\n* Presence of abdominal or umbilical hernias\n* Current pregnancy\n* Neuromuscular or systemic conditions affectinf the abdominal wall\n* Active infections\n* Any condition that could intervere with the correct execution of the measurement protocol.\n* Incomplete records or measurements that do not meet elastography quality criteria will be excluded.","FEMALE","18 Years",{"count":18,"type":19},30,"ESTIMATED","INTERVENTIONAL",[22],"NA","his study aims to evaluate the effect of an exercise program in postpartum women with diastasis recti, defined as an inter-rectus distance greater than 2 cm at any of three ultrasound measurement points . Participants will be divided into two groups: an intervention group that will follow a 6-week exercise program and a control group that will receive usual care.\n\nUltrasound assessment of the linea alba will be performed before the intervention and after 6 weeks. The main outcomes will be inter-rectus distance and the stiffness of the linea alba measured using shear wave elastography, along with obstetric and personal clinical variables. Participants will be recruited from primary care centers in the Community of Madrid through midwives during postpartum consultations.",[25],"Diastasis Recti And Weakness Of The Linea Alba",[27,28,29,30],"diastasis recti","Postpartum woman","exercise therapy","ultrasound","NOT_YET_RECRUITING","2026-06-05",{"date":34,"type":35},"2026-06-10","ACTUAL",{"date":37,"type":19},"2026-06",{"date":39,"type":19},"2026-09-30",{"name":41,"class":42},"University of Vigo","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":20,"phases":53,"briefSummary":54,"conditions":55,"keywords":59,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":43},"100628350","plyometric-strength-endurance-exercise-in-breast-cancer-100628350","NCT07460492","Plyometric Strength-Endurance Exercise in Breast Cancer","Therapeutic Plyometric-Based Strength-Endurance Exercise Program for Breast Cancer Patients and Survivors to Improve Quality of Life and Physical and Mental Function","Inclusion Criteria:\n\n* Women aged 18 years or older.\n* Prior diagnosis of breast cancer.\n* History of mastectomy, including unilateral procedures, total breast surgery, or breast-conserving surgery.\n* Completion of postoperative chemotherapy or radiotherapy, when indicated.\n* Absence of contraindications for physiotherapy or therapeutic exercise.\n* Willingness to voluntarily participate in the study.\n* Ability to understand and sign the informed consent form.\n* Availability to participate in the training program for the entire intervention period (approximately 12 weeks).\n\nExclusion Criteria\n\n* Participants will be excluded if any of the following conditions are present:\n* Active metastasis to other organs or tissues (e.g., liver, kidney, lung, brain) or stage IV cancer that prevents safe participation in the therapeutic exercise program.\n* Current diagnosis of cardiovascular, respiratory, neuromuscular, or musculoskeletal diseases that contraindicate physical exercise or impair safe completion of the program.\n* Major surgery within the previous 6 months without medical clearance to resume physical activity.\n* Cognitive impairment or mental health conditions that limit comprehension of instructions or safe engagement in the intervention.\n* Current pregnancy.\n* Lack of medical clearance for moderate-to-vigorous physical activity (as indicated by a medical certificate specifying the duration of the restriction and the conditions under which exercise may be resumed).",{"count":52,"type":19},51,[22],"This study aims to compare an adapted plyometric strength-endurance exercise program with conventional strength training in women who are breast cancer survivors or currently undergoing treatment and who participate in provincial support associations. The goal is to determine whether a targeted plyometric intervention can provide additional benefits in physical and mental health outcomes.\n\nUsing a cluster-randomized clinical trial design, the study will assess indicators such as functional capacity, muscle strength, fatigue levels, symptoms related to lymphedema, and overall quality of life. The findings are expected to contribute to a better understanding of how structured exercise programs can support recovery, physical function, and well-being in women affected by breast cancer.",[56,57,58],"Neoplams","Patients","Cancer Survivors",[60,61,62,63,64,65],"Randomized Controlled Trial","Cluster Analysis","quality of life","physical functional performance","functional status","mental health","2026-03-10",{"date":68,"type":35},"2026-03-13",{"date":70,"type":19},"2026-04-20",{"date":72,"type":19},"2027-12-31",{"name":41,"class":42},{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":82,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":4,"studyType":87,"phases":4,"briefSummary":88,"conditions":89,"keywords":4,"overallStatus":93,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":43},"100625190","isometric-strength-and-joint-mobility-profile-in-elite-artistic-swimmers-across-competitive-categories-100625190","NCT07419412","Isometric Strength and Joint Mobility Profile in Elite Artistic Swimmers Across Competitive Categories","General Assessment of Strength and Mobility in Artistic Swimmers of the Spanish Swimming Federation","Inclusion Criteria:\n\n* Elite artistic swimmers selected for the Spanish National Artistic Swimming Team (Infant, Junior, or Senior categories).\n* Age consistent with the competitive category: Infant 14-16 years, Junior 16-18 years, Senior ≥18 years.\n* Attendance at the national team training camp where the assessments are performed.\n* Voluntary participation with written informed consent (and assent\u002Fparental or legal guardian consent for minors).\n\nExclusion Criteria:\n\n* Acute musculoskeletal or joint injury affecting the tested regions (shoulder, hip, elbow, knee) at the time of assessment.\n* Chronic, previous, or any other condition that may limit participation or bias the measurements.\n* Inability to attend the assessment session(s) during the training camp.",true,"ALL","14 Years","50 Years",{"count":86,"type":19},45,"OBSERVATIONAL","This cross-sectional observational study aims to establish reference values for joint mobility and isometric muscle strength in elite artistic swimmers across different competitive categories. The study will analyze inter-limb asymmetries and agonist-antagonist strength ratios in upper and lower limbs. Additionally, relationships between isometric strength, countermovement jump performance, and handgrip strength will be explored to assess their utility as functional performance indicators. Participants will be assessed during national team training camps using standardized, validated measurement protocols. The findings are expected to contribute to the identification of sport-specific functional profiles and potential injury risk factors in artistic swimming.",[90,91,92],"Swimming","Stretch","Assessment, Self","RECRUITING","2026-02-19",{"date":96,"type":35},"2026-02-23",{"date":98,"type":35},"2026-01-10",{"date":100,"type":19},"2026-03-30",{"name":41,"class":42},{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":106,"acronym":4,"eligibilityCriteria":107,"healthyVolunteers":11,"sex":15,"minAge":108,"maxAge":109,"enrollmentInfo":110,"targetDuration":4,"studyType":20,"phases":112,"briefSummary":113,"conditions":114,"keywords":119,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":130,"completionDateStruct":132,"leadSponsor":134,"locationsCount":43},"100589273","effects-of-two-strength-exercise-programs-on-upper-limb-functionality-in-breast-cancer-100589273","NCT06952270","Effects of Two Strength Exercise Programs on Upper Limb Functionality in Breast Cancer","Inclusion Criteria:\n\n* Pathological diagnosis of breast cancer.\n* Patients who have undergone a mastectomy, including unilateral, total breast, or breast-conserving surgery.\n* Postoperative chemotherapy or radiotherapy as required.\n* No other malignant tumors in the last 5 years.\n* Absence of contraindications related to physiotherapy or physical exercise.\n* Willingness to participate in the study and sign the informed consent form.\n\nExclusion Criteria:\n\n* Metastasis to other organs and tissues (liver, kidney, lung, brain, etc.) that prevent participation in the exercise program.\n* Underlying heart disease, cerebrovascular disease, or mental illness that impairs proper execution of the exercise program.\n* Pre-existing shoulder pathology before surgery.\n* Inability to understand the plyometric exercise program.","25 Years","75 Years",{"count":111,"type":19},24,[22],"The goal of this experimental study is to evaluate the effect of a therapeutic exercise program based on upper limb plyometric exercises in breast cancer patients and breast cancer survivors to determine changes in upper limb functionality.\n\nThe main question it aims to answer is: Does upper limb plyometric strength exercise improve upper limb dysfunctions in breast cancer patients and survivors? The researchers will compare the effects of plyometric exercise with the effects of strength training exercise to determine whether plyometric exercise improves shoulder dysfunctions in breast cancer patients and survivors.\n\nParticipants from the Pontevedra group will undergo the intervention using plyometric exercise (Experimental Group), while those from the Vigo group will perform strength training exercise (Control Group). They will complete two sessions per week for six weeks. Outcome variables related to upper limb functionality will be assessed at baseline and after the intervention.",[115,116,117,118],"Breast Cancer Survivor","Breast Cancer","Breast Cancer Patients","Breast Cancer - Female",[120,121,122,123,124,125,126],"breast cancer","plyometric exercise","upper limb","strength training","exercise","Recovery of Function","clinical trial","2025-04-26",{"date":129,"type":35},"2025-04-30",{"date":131,"type":19},"2025-05-02",{"date":133,"type":19},"2025-07",{"name":41,"class":42},{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":4,"eligibilityCriteria":141,"healthyVolunteers":81,"sex":82,"minAge":83,"maxAge":16,"enrollmentInfo":142,"targetDuration":4,"studyType":20,"phases":144,"briefSummary":145,"conditions":146,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":4},"100588346","multidirectional-isometric-assessment-of-the-hip-100588346","NCT06940206","Multidirectional Isometric Assessment of the Hip","Multidirectional Isometric Assessment of the Hip in Young Swimmers","Inclusion Criteria:\n\n* Aged between 14 and 18 years.\n* Swimmers who train at least 15 hours weekly.\n* Swimmers who have participated in the national championship this season.\n\nExclusion Criteria:\n\n* Swimmers with any current hip or lower limb pathology.\n* Swimmers who have required hip surgery.\n* Swimmers who, for any other reason, are unable to complete an isometric maximal strength test.\n* No ability to perform the Multidirectional Isometric Assessment of the Hip without compensatory movements.\n* Refusal to sign informed consent (or legal guardian's consent for minors).",{"count":143,"type":19},55,[22],"With the exception of the shoulder, the hip is among the most frequently injured areas in swimmers. Despite this, hip injuries are often overlooked in training and prevention programmes. Such neglect can cause significant damage to muscles, particularly the adductors, and the joint itself, potentially requiring arthroscopic surgery or even leading to secondary injuries in related structures such as the knee. Furthermore, hip strength and range of motion directly affect swimmers' underwater kicking speed. Although hip assessments are common in other sports, like football, for injury prevention and performance analysis-both dynamically and isometrically-isometric testing is particularly recommended due to its higher reproducibility.\n\nTherefore, this study aims to validate a multidirectional isometric hip test in swimmers and examine agonist-antagonist muscle ratios in young advanced swimmers.\n\nA comparative analysis will be conducted on 30 elite swimmers. This will include a descriptive analysis of the group and comparative analyses between breaststroke\u002Fnon-breaststroke swimmers and between genders. Maximum isometric contractions of both lower limbs will be measured using a Chronojump force sensor (Boscosystem, Barcelona, Spain).\n\nAthletes will stand on a step positioned centrally within a rack or cage, either laterally or frontally depending on the movement assessed (ABD-ADD or flexion-extension, respectively). They will grip the appropriate supports with their hands and perform three maximal efforts of each movement lasting 3 seconds, without compensatory actions (any attempt with compensations will be discounted). There will be a 20-second rest between attempts. All three attempts will be recorded.\n\nTo assess measurement reliability, tests will be repeated after 48 hours for subsequent comparison.",[147,148,92],"Sports Physical Therapy","Hip","2025-04-23",{"date":151,"type":35},"2025-04-27",{"date":153,"type":19},"2025-04-28",{"date":155,"type":19},"2025-06-30",{"name":41,"class":42},{"id":158,"slug":159,"hasResults":11,"nctId":160,"briefTitle":161,"officialTitle":162,"acronym":4,"eligibilityCriteria":163,"healthyVolunteers":11,"sex":82,"minAge":16,"maxAge":164,"enrollmentInfo":165,"targetDuration":4,"studyType":20,"phases":167,"briefSummary":168,"conditions":169,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":173,"lastUpdatePostDateStruct":174,"startDateStruct":176,"completionDateStruct":178,"leadSponsor":180,"locationsCount":43},"100549690","effect-of-an-intervention-based-on-back-school-in-an-aquatic-environment-on-non-specific-low-back-pain-100549690","NCT06437314","Effect of an Intervention Based on Back School in an Aquatic Environment on Non-specific Low Back Pain","Effect of an Intervention Based on Back School in an Aquatic Environment on Non-specific Low Back Pain: Randomized Controlled Trial","Inclusion Criteria:\n\n* 18-65 years of age.\n* With non-specific low back pain for at least three months, with pain intensity (30-70 on a VAS).\n\nExclusion Criteria:\n\n* History of cancer, spine infection, rheumatologic diseases, history of spine fracture, history of trauma, red flag signs including unwanted weight loss (exceeding 10 percent of the total body weight) in the past six months and fever, history of psychological disease and history of spine surgery, radiculopathy, anatomical and congenital disturbance.\n* Missing more than two Back School sessions.\n* Not being able to attend the measurement sessions.","65 Years",{"count":166,"type":19},65,[22],"A controlled and randomized clinical trial will be conducted, in which scores on dependent variable measures will be compared before and after the intervention, both in the experimental group (EG) (individuals who will attend the in an aquatic program based on the back school) and in the control group (CG) (individuals who will not attend the in an aquatic program based on the back school). The experimental procedure will follow the recommendations of the CONSORT and TidIER guidelines. The study protocol will be approved by the Research Ethics Committee of the University of Vigo. This study will be conducted under the Declaration of Helsinki (2013 version). Participants will sign a written informed consent after being informed of the benefits and risks of the research. Participants in the EG will participate in an aquatic program based on the back school. This program will follow the recommendations of the biopsychosocial model of chronic pain and will be conducted in an aquatic environment. The intervention will be carried out by physiotherapists in a sports centre. The duration of the intervention will be six weeks, with a frequency of two sessions per week, totalling 12 sessions of 45 minutes each. Of all the sessions, 10 will have a practical focus and the other two will have a theoretical focus.",[170,171,172],"Low Back Pain","Exercise","Healthy","2025-03-18",{"date":175,"type":35},"2025-03-19",{"date":177,"type":19},"2025-04-10",{"date":179,"type":19},"2025-09-30",{"name":41,"class":42},{"id":182,"slug":183,"hasResults":11,"nctId":184,"briefTitle":185,"officialTitle":186,"acronym":187,"eligibilityCriteria":188,"healthyVolunteers":11,"sex":82,"minAge":16,"maxAge":4,"enrollmentInfo":189,"targetDuration":4,"studyType":20,"phases":191,"briefSummary":192,"conditions":193,"keywords":196,"overallStatus":93,"whyStopped":4,"lastUpdateSubmitDate":204,"lastUpdatePostDateStruct":205,"startDateStruct":207,"completionDateStruct":209,"leadSponsor":211,"locationsCount":212},"100320848","treatment-of-hypertension-during-sleep-100320848","NCT03457168","Treatment of Hypertension During Sleep","A Prospective, Randomized, Open-label Clinical Trial on the Effects of Intensive Versus Conventional Control of Ambulatory-determined Asleep Systolic Blood Pressure Mean on Cardiovascular, Metabolic, and Renal Disease Risks","THADEUS","Inclusion Criteria:\n\n1. Men and women aged ≥18 years.\n2. All participants must: (i) have at randomization sleep-time hypertension according to the current ESH\u002FESC guidelines, i.e., asleep SBP mean ≥120 mmHg;1 (ii) adhere to a routine of daytime activity and nighttime sleep; and (iii) provide their written informed consent to participate into the study.\n\nExclusion Criteria:\n\n1. Pregnancy.\n2. History of drug\u002Falcohol abuse within the last two years.\n3. Night\u002Fshift-work employment.\n4. Previous history of a systemic autoimmune disease or AIDS.\n5. Evidence of a secondary form of hypertension, including coarctation of the aorta, hyperaldosteronism, renal artery stenosis, or pheochromocytoma\n6. CVD disorders (unstable angina pectoris, heart failure, life-threatening arrhythmia, atrial fibrillation, kidney failure, and grade III-IV retinopathy). Previous CVD events will not be exclusionary if full physical and work activities are maintained.\n7. Any surgical or medical condition which might alter the absorption, distribution, metabolism, or excretion of any drug, or, at the discretion of the investigator, might place the subject at higher risk from his\u002Fher participation in the study, or are likely to prevent the subject from complying with the requirements of the study or completing the trial period.\n8. History of malignancy including leukemia and lymphoma (but not basal cell skin cancer), or any other severe, life-threatening disease within the past five years.\n9. Inability to communicate and comply with all study requirements.\n10. Intolerance to ABPM.",{"count":190,"type":19},5320,[22],"On the basis of new evidence on the relationship between achieved office blood pressure (BP) measurements (OBPM) and the risk of cardiovascular disease (CVD) morbidity and mortality documented in the SPRINT trial, the recent 2017 guidelines of the American College of Cardiology (ACC) and the American Heart Association (AHA) have established lower values of 130\u002F80 mmHg for clinic systolic BP (SBP)\u002Fdiastolic BP (DBP) as new diagnostic thresholds for hypertension and therapeutic targets for treatment of all individuals aged ≥18 years regardless of age, sex, or concomitant complications including presence of diabetes, chronic kidney disease (CKD), or history of past CVD event. According to these guidelines, the new proposed ambulatory BP measurment (ABPM) thresholds for diagnosis of hypertension in adults are 130\u002F80 and 110\u002F65 mmHg for the awake and asleep SBP\u002FDBP means, respectively. However, the ACC\u002FAHA guidelines do not provide any scientific evidence documenting neither the equivalence between these ABPM thresholds and the 130\u002F80 mmHg cut-off values for OBPM nor the potential improved CVD event-free survival time of the proposed more intensive control of ambulatory BP.\n\nResults derived from observational prospective studies consistently document that therapeutic BP targets in hypertensive individuals, i.e., persons at increased CVD risk, should be established in terms of proper control of asleep BP. To date, no prospective randomized study has ever before evaluated which should be the adequate therapeutic ABPM target for most effective reduction of CVD risk. Accordingly, the Tratamiento de Hipertensión Arterial Durante el Sueño study (THADEUS, i.e., Treatment of Hypertension During Sleep) has been designed to prospectively evaluate if \"intensive control\" of asleep SBP mean proposed by the new ACC\u002FAHA guidelines (\\\u003C110 mmHg) in more effective than the so far its \"conventional control\" (\\\u003C120 mmHg) to reduce CVD morbidity and mortality in hypertensive individuals.",[194,195],"Hypertension","Hypertension, Systolic",[197,198,199,200,201,202,203],"Sleep-time hypertension","Ambulatory blood pressure monitoring","Hypertension chronotherapy","Asleep blood pressure","Cardiovascular risk","Type 2 diabetes","Chronic kidney disease","2024-12-03",{"date":206,"type":35},"2024-12-06",{"date":208,"type":35},"2019-02-01",{"date":210,"type":19},"2032-12-31",{"name":41,"class":42},9,{"id":214,"slug":215,"hasResults":11,"nctId":216,"briefTitle":217,"officialTitle":217,"acronym":4,"eligibilityCriteria":218,"healthyVolunteers":81,"sex":82,"minAge":16,"maxAge":219,"enrollmentInfo":220,"targetDuration":4,"studyType":20,"phases":222,"briefSummary":223,"conditions":224,"keywords":226,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":231,"lastUpdatePostDateStruct":232,"startDateStruct":234,"completionDateStruct":236,"leadSponsor":238,"locationsCount":4},"100563616","effects-of-kinesiotape-or-neuromuscular-taping-on-the-activation-of-the-transversus-abdominis-muscle-a-pilot-study-100563616","NCT06618482","Effects of Kinesiotape or Neuromuscular Taping on the Activation of the Transversus Abdominis Muscle. A Pilot Study","Inclusion Criteria:\n\n* The participants are members of the UVIGO who voluntarily participate in the study with an age between 18 and 35 years.\n* The participants are healthy subjects (men and women) of legal age.\n* All subjects must sign the informed consent prior to the experimentation.\n\nExclusion Criteria:\n\n* \\- Suffering from skin disorders, fragile skin or allergy to adhesive bandages.\n* Elite athletes.\n* Excessive skin hair in the region to apply the bandage.\n* Receive a bandage in the abdominal or lumbar region two weeks prior to the experiment.\n* History of orthopedic\u002Ftraumatic alterations in the lumbopelvic region (deformities, arthrodesis, arthropathy, muscle injuries, fracture or tendinopathy), neurological disorders (central or peripheral), systemic disorders, circulatory disorders (edema, heart failure, thrombosis, renal failure), or surgery in the abdominal-lumbar region in the last 6 months.\n* Perform abdominal or lumbar strength training 48 hours prior to the study.\n* Limitation greater than 50% in the flexion-extension range of motion of the lumbar spine.\n* Consumption of alcoholic beverages or medications 24 hours prior to the experimentation.\n* Pregnancy or having given birth in less than a year.","35 Years",{"count":221,"type":19},12,[22],"The use of adhesive bandages is a widely practiced technique in both clinical and sports settings. There is a great variety of materials used for bandaging, with multiple objectives: limiting movement, correcting joint positions, reducing pain, enhancing sports performance, and reducing the number of injuries.\n\nHowever, current knowledge about their potential effects is still limited, and more studies are needed to determine the most appropriate application parameters.\n\nFor this reason, the objective of the study for which we request your collaboration is to determine to what extent the application of an adhesive bandage (neuromuscular tape) can influence muscle facilitation through fiber recruitment and strength development, to improve performance during exercise.\n\nThe information derived from this research will provide a better understanding of the influence that an adhesive bandage (neuromuscular tape) can have on the neuromuscular system and on strength enhancement.",[225],"Healthy Subjects (HS)",[227,228,229,230],"Kinesiotape","Bandage","Transverse Abdominal","Abdominal Ultrasound","2024-09-25",{"date":233,"type":35},"2024-10-01",{"date":235,"type":19},"2024-09-30",{"date":237,"type":19},"2024-10-16",{"name":41,"class":42},""]